Showing results (141-150 of 688) with videos related to

Sort By:
Pageof 69
Life Sciences|January 1, 1989
Failure to find Ca2(+)-dependent proteinase (calpain) activity in a plant species, Elodea densaF H Wolfe, A Szpacenko, K McGee, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1979
The significance of proteinuria and haematuria in Schistosoma haematobium infectionH A Wilkins, P Goll, T F Marshall, et al.
Clinical Neurology and Neurosurgery|January 14, 2022
Comparison of sagittal vertical axis and decompression on the clinical outcome of cervical spondylotic myelopathyDaniel Koeppen, Henrik Stelling, Moritz Goll, et al.
Clinical Immunology (Orlando, Fla.)|September 10, 2017
Increased expression of interleukin-21 along colorectal adenoma-carcinoma sequence and its predicating significance in patients with sporadic colorectal cancerGuanglin Cui, Aping Yuan, Li Zhu, et al.
Infection|July 25, 2007
Different trends of MRSA and VRE in a German hospital, 1999-2005C Goll, P Balmer, F Schwab, et al.
Scandinavian Journal of Gastroenterology|March 19, 2009
Infliximab therapy decreases the levels of TNF-alpha and IFN-gamma mRNA in colonic mucosa of ulcerative colitisTrine Olsen, Guanglin Cui, Rasmus Goll, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 10, 2022
The presentation and regulation of the IL-8 network in the epithelial cancer stem-like cell niche in patients with colorectal cancerGuanglin Cui, Gui Li, Zhigang Pang, et al.
Cancer Immunology, Immunotherapy : CII|April 8, 2009
Dynamic changes of interleukin-8 network along the colorectal adenoma-carcinoma sequenceGuanglin Cui, Aping Yuan, Rasmus Goll, et al.
Ebiomedicine|April 16, 2021
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkersGuanglin Cui, Qingbo Fan, Zhenfeng Li, et al.
Ebiomedicine|December 27, 2019
The effect of fecal microbiota transplantation on IBS related quality of life and fatigue in moderate to severe non-constipated irritable bowel: Secondary endpoints of a double blind, randomized, placebo-controlled trialPeter Holger Johnsen, Frank Hilpüsch, Per Christian Valle, et al.
Pageof 69